Literature DB >> 15850920

1998-1999 patterns of care study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of stage I-II breast cancer.

Lori J Pierce1, Jennifer Moughan, Julia White, David P Winchester, Jean Owen, J Frank Wilson.   

Abstract

PURPOSE: The Patterns of Care Study survey process evaluation has been an effective means of assessing the evaluation and treatment practices used by radiation oncologists in the United States for Stage I-II breast cancer. The current 1998-1999 report updates the previous 1989 and 1993-1994 analyses and reflects the recent changes in surgery and systemic therapy observed nationally in the management of early-stage disease. METHODS AND MATERIALS: A weighted sample size of 71,877 patient records of women treated with breast-conserving surgery and radiotherapy (RT) was obtained from a stratified two-stage sampling of 353 patient records. These cases were centrally reviewed from academic and private radiation oncology practices across the United States. The data collected included patient characteristics, clinical and pathologic factors, and surgical and RT details. The results were compared with those of previous Patterns of Care Study survey reports.
RESULTS: Of the patients in the current survey, 97% had undergone mammography before biopsy. A review of the primary tumor pathologic findings indicated improved quantification of an intraductal component from 7.0% in 1993-1994 to 20.4% in 1998-1999 (p = 0.01). The tumor characteristics were better defined, with estrogen and progesterone receptor measurement performed in 91.4% and 91.3% in the 1998-1999 survey vs. 83.7% and 80.3% in the 1989 survey, respectively (p = 0.03 and p = 0.002, respectively). Axillary dissection was performed in 82.2% in the present survey compared with 93.6% in the 1993-1994 survey (p = 0.0004); sentinel node biopsy was performed in 20.1% of the present cases. The use of CT for planning was increased in the current survey, with 22.9% cases CT planned vs. 9% in 1993-1994 (p = 0.10). In the present survey, 100% had received whole breast RT. When a supraclavicular field was added, the dose was prescribed to a specified depth in 67.5% of cases, most commonly 3 cm. When an axillary field was added, the dose was generally prescribed to the mid-plane. Chemotherapy and tamoxifen was used in 36% and 55.8% of patients, respectively, in the 1998-1999 survey, representing a statistically significant increase compared with the 1993-1994 survey, despite comparable pathologic tumor size and nodal involvement.
CONCLUSION: The present results demonstrate a high level of compliance of the sampled radiation oncology practices with current breast conservation standards and continued improvement in many categories compared with prior patterns of care study surveys. The estimates in the current survey after whole breast RT will serve as a benchmark against newer trends in breast cancer RT, such as partial breast RT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850920     DOI: 10.1016/j.ijrobp.2004.09.019

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Risk factors for lymphedema after breast cancer treatment.

Authors:  Sandra A Norman; A Russell Localio; Michael J Kallan; Anita L Weber; Heather A Simoes Torpey; Sheryl L Potashnik; Linda T Miller; Kevin R Fox; Angela DeMichele; Lawrence J Solin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-26       Impact factor: 4.254

2.  Evaluation of adaptive radiotherapy (ART) by use of replanning the tumor bed boost with repeated computed tomography (CT) simulation after whole breast irradiation (WBI) for breast cancer patients having clinically evident seroma.

Authors:  Omer Sager; Ferrat Dincoglan; Bora Uysal; Selcuk Demiral; Hakan Gamsiz; Yelda Elcim; Esin Gundem; Bahar Dirican; Murat Beyzadeoglu
Journal:  Jpn J Radiol       Date:  2018-04-05       Impact factor: 2.374

3.  Acute Toxicity From Breast Cancer Radiation Using Helical Tomotherapy With a Simultaneous Integrated Boost.

Authors:  Andrzej P Wojcieszynski; Anna K Olson; Yi Rong; Randall J Kimple; Poonam Yadav
Journal:  Technol Cancer Res Treat       Date:  2015-03-16

4.  Disparities in breast cancer treatment and survival for women with disabilities.

Authors:  Ellen P McCarthy; Long H Ngo; Richard G Roetzheim; Thomas N Chirikos; Donglin Li; Reed E Drews; Lisa I Iezzoni
Journal:  Ann Intern Med       Date:  2006-11-07       Impact factor: 25.391

5.  Treatment optimization using computed tomography-delineated targets should be used for supraclavicular irradiation for breast cancer.

Authors:  Raweewan Liengsawangwong; Tse-Kuan Yu; Tzouh-Liang Sun; Jeremy J Erasmus; George H Perkins; Welela Tereffe; Julia L Oh; Wendy A Woodward; Eric A Strom; Mohammad Salephour; Thomas A Buchholz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-01       Impact factor: 7.038

6.  The effect of adjuvant radiotherapy on mortality differs according to primary tumor location in women with node-positive breast cancer.

Authors:  Vincent Vinh-Hung; Pauline T Truong; Wolfgang Janni; Nam Phong Nguyen; Georges Vlastos; Gábor Cserni; Melanie E Royce; Wendy A Woodward; Donald Promish; Patricia Tai; Guy Soete; Sabine Balmer-Majno; Bruno Cutuli; Guy Storme; Christine Bouchardy
Journal:  Strahlenther Onkol       Date:  2009-03-28       Impact factor: 3.621

7.  Supraclavicular failure after breast-conserving therapy in patients with four or more positive axillary lymph nodes when prophylactic supraclavicular irradiation is omitted.

Authors:  Yasushi Hamamoto; Masaaki Kataoka; Takatoshi Semba; Kotaro Uwatsu; Yoshifumi Sugawara; Takeshi Inoue; Shinya Sakai; Shoji Aono; Tadaaki Takahashi; Shogo Oda
Journal:  Jpn J Radiol       Date:  2009-06-25       Impact factor: 2.374

8.  Can radiographic plain film be used to determine the depth of the tumour bed in the absence of surgical clips for breast boost planning.

Authors:  I Chitapanarux; M Muttarak; W Na-Chiangmai; H Trakultivakorn; A Somwangprasert; P Kamnerdsupaphon; E Tharavichitkul; V Sukthomya; V Lorvidhaya; A Watcharawipha
Journal:  Biomed Imaging Interv J       Date:  2009-07-01

9.  Regional lymph node radiotherapy in breast cancer: single anterior supraclavicular field vs. two anterior and posterior opposed supraclavicular fields.

Authors:  Mohammad Houshyari; Amir Shahram Yousefi Kashi; Sakineh Soleimani Varaki; Afshin Rakhsha; Eftekhar Rajab Blookat
Journal:  Electron Physician       Date:  2015-06-05

10.  Using relative survival measures for cross-sectional and longitudinal benchmarks of countries, states, and districts: the BenchRelSurv- and BenchRelSurvPlot-macros.

Authors:  Christian O Jacke; Iris Reinhard; Ute S Albert
Journal:  BMC Public Health       Date:  2013-01-14       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.